Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
暂无分享,去创建一个
C. Wheelock | P. Knolle | U. Protzer | C. Schmidt‐Weber | J. Kolmert | P. Lingor | J. Esser-von Bieren | F. Hartung | A. Quaranta | J. Erber | A. Chaker | A. Lechner | Fiona D R Henkel | Sina Bohnacker | Lisa Pechtold | Alina Priller | Sarah Yazici | Johanna Giglberger | Luisa M. Kugler | M. Ud-Dean | Fiona D. R. Henkel | Minhaz Ud-Dean | Julia Esser-von Bieren
[1] Guohui Fan,et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.
[2] A. Mitra,et al. Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation , 2021, Mucosal immunology.
[3] N. Flamand,et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19 , 2021, Journal of Allergy and Clinical Immunology.
[4] Mark M. Davis,et al. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19 , 2021, Nature Cell Biology.
[5] N. Flamand,et al. High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] P. Nilsson,et al. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. , 2021, JAMA.
[7] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[8] Sinead E. Morris,et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19 , 2021, Immunity.
[9] M. Giera,et al. Sema7A is crucial for resolution of severe inflammation , 2021, Proceedings of the National Academy of Sciences.
[10] Lydia M. Roberts,et al. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators , 2020, The Journal of Immunology.
[11] M. Menden,et al. Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany , 2020, medRxiv.
[12] M. Fassan,et al. The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation , 2020, Scientific Reports.
[13] P. Howarth,et al. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study , 2020, American journal of respiratory and critical care medicine.
[14] C. Dooms,et al. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages , 2020, Cell Research.
[15] Lydia M. Roberts,et al. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators , 2020, medRxiv.
[16] D. Panigrahy,et al. Eicosanoids , 2020, The American Journal of Pathology.
[17] Roland Eils,et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.
[18] Quanxin Long,et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.
[19] J. Adamski,et al. Inflammatory macrophage memory in NSAID-exacerbated respiratory disease. , 2020, The Journal of allergy and clinical immunology.
[20] Lin Cheng,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[21] Sui Huang,et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? , 2020, Cancer and Metastasis Reviews.
[22] M. Merad,et al. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.
[23] Linqi Zhang,et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.
[24] Seena K. Ajit,et al. Xist attenuates acute inflammatory response by female cells , 2020, Cellular and Molecular Life Sciences.
[25] Noula Shembade,et al. An Essential Role for Perforin-2 in Type I IFN Signaling , 2020, Journal of Immunology.
[26] P. Horby,et al. A novel coronavirus outbreak of global health concern , 2020, The Lancet.
[27] M. Mack,et al. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection , 2019, Nature Immunology.
[28] D. Vinh,et al. Leukotriene B4–type I interferon axis regulates macrophage-mediated disease tolerance to influenza infection , 2019, Nature Microbiology.
[29] J. Schertzer,et al. Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity , 2018, Cell.
[30] S. Dahlén,et al. Lipid Mediator Quantification in Isolated Human and Guinea Pig Airways: An Expanded Approach for Respiratory Research. , 2018, Analytical chemistry.
[31] Gang Liu,et al. Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.
[32] B. Becher,et al. The Cytokine TGF‐&bgr; Promotes the Development and Homeostasis of Alveolar Macrophages , 2017, Immunity.
[33] J. Esser-von Bieren,et al. Immune-regulation and -functions of eicosanoid lipid mediators , 2017, Biological chemistry.
[34] O. Rådmark,et al. Age dictates a steroid‐resistant cascade of Wnt5a, transglutaminase 2, and leukotrienes in inflamed airways , 2017, The Journal of allergy and clinical immunology.
[35] D. Brealey,et al. Evidence for chemokine synergy during neutrophil migration in ARDS , 2016, Thorax.
[36] Qing-lin Han,et al. CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma. , 2016, International immunopharmacology.
[37] F. Cunha,et al. CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis , 2015, Arthritis & rheumatology.
[38] M. Kurrer,et al. Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages , 2014, Nature Immunology.
[39] J. L. Schwartz,et al. Fcgbp – A Potential Viral Trap in RV144 , 2014, The open AIDS journal.
[40] G. Wong,et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. , 2014, Immunity.
[41] W. Gause,et al. Antibodies Trap Tissue Migrating Helminth Larvae and Prevent Tissue Damage by Driving IL-4Rα-Independent Alternative Differentiation of Macrophages , 2013, PLoS pathogens.
[42] C. Karp,et al. Role of the Lipoxygenase Pathway in RSV-induced Alternatively Activated Macrophages Leading to Resolution of Lung Pathology , 2013, Mucosal Immunology.
[43] M. Halushka,et al. A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart Block* , 2011, The Journal of Biological Chemistry.
[44] A. Vieira-de-Abreu,et al. Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 Controls Microtubule-Driven Biogenesis and Leukotriene B4-Synthesizing Function of Macrophage Lipid Bodies Elicited by Innate Immune Response1 , 2007, The Journal of Immunology.
[45] T. Ichiyama,et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[46] Larissa B. Thackray,et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] Jilly F. Evans,et al. Leukotriene B4 Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[48] U. Schauer,et al. Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells , 2002, Clinical and experimental immunology.
[49] H. Neumann,et al. Anti‐inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration , 2001, European journal of immunology.
[50] M. Peters-Golden,et al. Prolonged Exposure to Lipopolysaccharide Inhibits Macrophage 5-Lipoxygenase Metabolism Via Induction of Nitric Oxide Synthesis1 , 2000, The Journal of Immunology.
[51] H. Zhu,et al. Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Suematsu,et al. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. , 1999, The Journal of clinical investigation.
[53] J. Baker,et al. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. , 1997, European journal of biochemistry.
[54] G. Manso,et al. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. , 1992, The European respiratory journal.
[55] Robert A. Lewis,et al. Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.
[56] J. Adamski,et al. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease , 2020 .
[57] B. Hammock,et al. The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)? , 2022 .